scispace - formally typeset
M

Myron S. Cohen

Researcher at University of North Carolina at Chapel Hill

Publications -  576
Citations -  50913

Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.

Papers
More filters
Journal ArticleDOI

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

TL;DR: Estimates of the heterosexual infectivity of HIV-1 were very heterogeneous, ranging from zero transmissions after more than 100 penile-vaginal contacts in some serodiscordant couples to one transmission for every 3.1 episodes of heterosexual anal intercourse.
Journal ArticleDOI

Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission

TL;DR: This study demonstrates that the penetration of different human mucosal tissues and their exposure to the pro-drugs TFV and FTC and their active metabolites TFV-DP and FTC-TP is wide ranging and dependent on the tissue type, and reinforces the fact that the success of PrEP will depend on selecting the correct ART that achieves a critical concentration and duration of exposure in vulnerable mucosal tissue.
Journal ArticleDOI

Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

TL;DR: The results emphasized the importance of phagocytic cells in defense against fungi and the need for further evaluation of granulocyte transfusion therapy in compromised hosts in whom fungal infections develop.
Journal ArticleDOI

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe Malawi: a modelling study.

TL;DR: The results suggest that early infection plays an important part in HIV transmission in this sub-Saharan African setting, and interventions during chronic infection will probably have incomplete effectiveness unless complemented by strategies targeting individuals with early HIV infection.